PSA Progression: Clinical Trials

2 trials for PSA Progression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow PSA Progression: new trials by email Literature Review of PSA Progression trials Research Report on PSA Progression

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Carboplatin, Docetaxel, Laboratory Biomarker Analysis - ATM Gene Mutation, BRCA1 Gene Mutation
Phase 2TerminatedUniversity of Washington182018-08-242026-08-26
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
Selinexor - Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer
Phase 2TerminatedUniversity of California, San Francisco142014-09-022018-06-26

Interventions

Carboplatin (1)  ·  Docetaxel (1)  ·  rucaparib (1)  ·  selinexor (1)

Sponsors

University of California, San Francisco (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Charles Ryan, MD (1)  ·  Heather H. Cheng (1)

Results publications

PMID 29487219